# Fosrenol and Phosphorus Balance - Lanthanum Carbonate

> **NCT01581996** · NA · COMPLETED · sponsor: **Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center** · enrollment: 9 (actual)

## Conditions studied

- Chronic Kidney Failure
- End-stage Renal Disease
- Disorders Associated With Peritoneal Dialysis

## Interventions

- **DRUG:** lanthanum carbonate

## Key facts

- **NCT ID:** NCT01581996
- **Lead sponsor:** Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2017-05
- **Final completion:** 2017-05
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2017-05-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01581996

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01581996, "Fosrenol and Phosphorus Balance - Lanthanum Carbonate". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01581996. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*